Kimihiko Takada

431 total citations
19 papers, 334 citations indexed

About

Kimihiko Takada is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Kimihiko Takada has authored 19 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Oncology. Recurrent topics in Kimihiko Takada's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Cell death mechanisms and regulation (3 papers) and Immune Response and Inflammation (3 papers). Kimihiko Takada is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), Cell death mechanisms and regulation (3 papers) and Immune Response and Inflammation (3 papers). Kimihiko Takada collaborates with scholars based in Japan. Kimihiko Takada's co-authors include Hidemi Ishii, Toshiyuki Higuchi, Yutaka Masuda, Junichi Kitajima, Junichi Sugiyama, Yutaka Masuda, Shuichi Horie, Koji Oida, Hiroyuki Ishikawa and Maki Ishii and has published in prestigious journals such as Blood, Biochemical Pharmacology and Toxicology and Applied Pharmacology.

In The Last Decade

Kimihiko Takada

19 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimihiko Takada Japan 12 155 60 55 54 38 19 334
Pei Yu China 12 183 1.2× 94 1.6× 19 0.3× 28 0.5× 49 1.3× 34 425
Yong‐Liang Chu China 11 143 0.9× 40 0.7× 21 0.4× 50 0.9× 58 1.5× 14 319
Meng Chen China 13 240 1.5× 51 0.8× 47 0.9× 14 0.3× 88 2.3× 36 435
Sook‐Kyoung Heo South Korea 16 235 1.5× 183 3.0× 122 2.2× 75 1.4× 45 1.2× 36 648
Alberto Monasterio Spain 6 127 0.8× 34 0.6× 23 0.4× 26 0.5× 64 1.7× 6 302
M. V. Gazzola Italy 7 105 0.7× 68 1.1× 60 1.1× 193 3.6× 15 0.4× 10 441
Shuangfeng Xie China 10 147 0.9× 42 0.7× 94 1.7× 12 0.2× 34 0.9× 35 333
Mina Yazdi Iran 8 144 0.9× 43 0.7× 20 0.4× 24 0.4× 56 1.5× 14 384
Barun Poudel South Korea 12 224 1.4× 95 1.6× 16 0.3× 20 0.4× 59 1.6× 18 472
Asuman Mutlu Canada 10 213 1.4× 52 0.9× 139 2.5× 99 1.8× 9 0.2× 13 449

Countries citing papers authored by Kimihiko Takada

Since Specialization
Citations

This map shows the geographic impact of Kimihiko Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimihiko Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimihiko Takada more than expected).

Fields of papers citing papers by Kimihiko Takada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimihiko Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimihiko Takada. The network helps show where Kimihiko Takada may publish in the future.

Co-authorship network of co-authors of Kimihiko Takada

This figure shows the co-authorship network connecting the top 25 collaborators of Kimihiko Takada. A scholar is included among the top collaborators of Kimihiko Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimihiko Takada. Kimihiko Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Takada, Kimihiko, et al.. (2024). Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells. Cancer Chemotherapy and Pharmacology. 94(6). 763–774. 1 indexed citations
3.
Takada, Kimihiko, et al.. (2019). Prexasertib increases the sensitivity of pancreatic cancer cells to gemcitabine and S‑1. Oncology Reports. 43(2). 689–699. 12 indexed citations
4.
Masuda, Yutaka, et al.. (2015). PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells. Biological and Pharmaceutical Bulletin. 38(10). 1529–1535. 3 indexed citations
5.
7.
Takada, Kimihiko, et al.. (2013). Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition. Thrombosis and Haemostasis. 109(6). 1060–1069. 6 indexed citations
9.
Sasaki, Tomoyuki, Nobuko Yoshimoto, Katsuyoshi Sugimoto, et al.. (2012). Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis. Thrombosis Research. 130(4). e222–e228. 7 indexed citations
10.
Kojima, Yuka, et al.. (2009). Expression of thrombin-activatable fibrinolysis inhibitor (TAFI) is up-regulated by increase in intracellular cyclic AMP levels in cultured HepG2 cells. Thrombosis and Haemostasis. 102(12). 1204–1211. 7 indexed citations
11.
12.
Murata, Kazuya, Toshiyuki Higuchi, Kimihiko Takada, et al.. (2006). Verotoxin-1 stimulation of macrophage-like THP-1 cells up-regulates tissue factor expression through activation of c-Yes tyrosine kinase: Possible signal transduction in tissue factor up-regulation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(9). 835–843. 15 indexed citations
14.
Ishii, Hidemi & Kimihiko Takada. (2002). Bleomycin Induces E-selectin Expression in Cultured Umbilical Vein Endothelial Cells by Increasing Its mRNA Levels through Activation of NF-κB/Rel. Toxicology and Applied Pharmacology. 184(2). 88–97. 29 indexed citations
15.
Takada, Kimihiko, Toshiyuki Higuchi, Junichi Sugiyama, & Hidemi Ishii. (2000). Verotoxin-1 Induces Tissue Factor Expression in Human Umbilical Vein Endothelial Cells through Activation of NF-κB/Rel and AP-1. Thrombosis and Haemostasis. 84(10). 712–721. 20 indexed citations
16.
Ishii, Hidemi, Kimihiko Takada, Toshiyuki Higuchi, & Junichi Sugiyama. (2000). Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1.. PubMed. 84(4). 712–21. 29 indexed citations
17.
Tanaka, Mitsuo, et al.. (1996). Thiopalmitic Acid-Mediated Fe(III)-Nitrilotriacetate Reduction and Lipid Peroxidation.. Biological and Pharmaceutical Bulletin. 19(5). 678–682. 1 indexed citations
18.
Sasaki, Hiroshi, Kimihiko Takada, Yoshiteru Terashima, et al.. (1991). Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and l-phenylalanine mustard are sensitive to Δ7-prostaglandin Δ1 and Δ12-prostaglandin J2. Gynecologic Oncology. 41(1). 36–40. 26 indexed citations
19.
Ekimoto, H, Kimihiko Takada, Katsutoshi Takahashi, et al.. (1987). Different Sensitivity to Bleomycin-Induced Pulmonary Fibrosis among Various Strains of Mice. Journal of Clinical Biochemistry and Nutrition. 2(1). 25–31. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026